Content - IELSG-42

IELSG-42 - Tolerability and efficacy of the MARIETTA regimen

For further information about the trial IELSG-42 please visit the IBCSG-Website: www.ielsg.org

Study Chair:

Prof. Dr. Emanuele Zucca, IOSI, +41 91 811 91 47

Locations for this trial:

Istituto Oncologico della Svizzera Italiana IOSI
Via Ospedale
0 6500 Bellinzona